It has been demonstrated that, in RA patients, CD21low B cells constituted almost half of the B cells in the synovial fluid of the inflamed joints, due to their expression of the inflammatory chemokine receptor CXCR-3 and the secretion of its ligand, CXCL-9 [12]. This evidence concerns the gene CXCL9 and rheumatoid arthritis.